Association of a BACE1 Gene Polymorphism with Parkinson's Disease in a Norwegian Population. (14th December 2015)

• Record Type: Journal Article
• Authors: Lange, Johannes; Lunde, Kristin Aaser; Sletten, Camilla; Møller, Simon Geir; Tysnes, Ole-Bjørn; Alves, Guido; Larsen, Jan Petter; Maple-Grødem, Jodi
• Other Names: Pisani Antonio Academic Editor.
• Is Part Of: Parkinson's disease. Volume 2015(2015)
• Publication Date: 2015-12-14
• Subjects: Parkinson's disease -- Periodicals; Parkinson's disease -- Treatment -- Periodicals; 616.833005
• DOI: 10.1155/2015/973298
• Languages: English
• ISSNs: 2090-8083

Abstract

Abstract : Background . Parkinson's disease (PD) and Alzheimer's disease (AD) share pathological features, including amyloid-beta pathology. Amyloid-beta peptide is generated by sequential proteolysis of amyloid precursor protein (APP), and genetic variations in the processing pathway genes have been found to increase the risk of AD; however, the contribution in PD is unknown. Methods . The aim of this study was to investigate whether candidate polymorphisms in five genes ( ADAM10, BACE1, BACE2, PSEN2, and CLU ) involved in the APP processing pathway affect PD risk in a population-based cohort of patients with incident PD and control subjects from the Norwegian ParkWest study. Results . We found an association of rs638405 in BACE1 with increased risk of PD, thus providing a novel link, at the genetic level, between amyloid-beta pathology and PD.